Ian Karet > Linklaters LLP > London, England > Lawyer Profile

Linklaters LLP
ONE SILK STREET
LONDON
EC2Y 8HQ
England
Ian Karet photo

Work Department

Intellectual property; TMT.

Position

Ian specializes in intellectual property and technology and covers commercial work and disputes. He is a qualified arbitrator and mediator. Significant cases include Merck v Merck, ICC royalty arbitration, Aerotel v Telco, Actavis v Merck, 32Red v William Hill and Tate & Lyle v Roquette. He is a solicitor advocate and a qualified arbitrator and mediator.

Career

Articled clerk Linklaters, London 1987-89; assistant solicitor London 1990-97; partner London 1997. Ian is on the editorial boards of ‘European Intellectual Property Review’ and ‘Journal of Intellectual Property Law and Practice’. Member of the Civil Justice Council and Trustee of the Royal Botanic Gardens, Kew

Memberships

Member of Honour of AIPPI; vice-president AIPPI UK.

Education

Oxford University (MA Chemistry)

Lawyer Rankings

London > TMT (technology, media and telecoms) > Intellectual property: patents (contentious and non-contentious)

The ‘extremely diligent and creative’ team at Linklaters LLP is positioned at the crux of multiple sectors and is able to advise across these, utilising its varied experience that is comprised of contentious and non-contentious mandates for pharmaceutical and biotech companies. The practice is jointly helmed by four key players: Ian Karet, who possesses more than 30 years of experience in the field, Yohan Liyanage, who is notably well-versed in the technology space, the ‘extremely good patent litigator’ Katie Coltart, who brought her expertise in biologics and biosimilars from Kirkland & Ellis International LLP in October 2023, and Paul Joseph, whose litany of experience extends from technology patent litigation to joint venture agreements. Stephanie Farrington principally focuses on the healthcare and life sciences sector.

London > TMT (technology, media and telecoms) > Intellectual property: trade marks, copyright and design

Ian Karet, Yohan Liyanage, Paul Joseph, and Katie Coltart lead the team at Linklaters LLP, which has handled some notable trade mark litigation and IP licensing arrangements. Karet is active in the industries of pharmaceuticals and technology, and Liyanage is routinely engaged by clients for assistance with licensing and commercialisation arrangements. Joseph’s wide-ranging capabilities are comprised of copyright disputes, commercialisation, and IP structuring mandates, among others. Coltart joined from Kirkland & Ellis International LLP in October 2023. Jennifer Heley is another key name to note with her transactional strengths.

London > Industry focus > Life sciences and healthcare

Praised for its ability to provide creative solutions tailored to bespoke situations, Linklaters LLP assists a litany of major pharmaceutical, biotech, digital health and medical device companies with work including transactions, patent and trade mark litigations and licensing disputes. Marly Didizian, described as ‘first choice for the tricky stuff’, co-heads the team and is noted on the market for her ability to handle high-profile pharma mergers and carve-outs. Fellow co-head Aisling Zarraga is equipped to handle matters spanning M&A, joint ventures and corporate governance advisory work. IP expert Yohan Liyanage assists clients with IP transactions and patent litigation. Trade mark and patent disputes are staples of Ian Karet‘s far-reaching practice. Katie Coltart has a proven track record in coordinating cross-border patent litigation.